Pinnacle財務合伙人公 PNFP 深 滬
等待開盤 12-25 09:30:00 美东时间
101.30
+0.050
+0.05%
華盛通- 最 高101.63
- 今 開101.37
- 成交量 46.16万股
- 最 低 100.865
- 昨 收 101.25
- 總市值 78.58亿
- 52周最高 126.89
- 市盈率 靜 16.99
- 換手率 0.60%
- 52周最低 80.85
- 委 比 -23.08%
- 總股本 7757.55万
- 歷史最高 130.95
- 量 比 0.86
- 振 幅 0.76%
- 歷史最低 2.27
- 每 手 1
- 風險率 11.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Going On With UiPath Shares Wednesday?
UiPath, Inc. (NYSE:PATH) shares are trading higher Wednesday after it was announced that the company replace Synovus in the S&P MidCap 400.
今天 01:00
UiPath Stock Is Rising After The Bell: Here's Why
UiPath Inc (NYSE:PATH) shares are moving higher in extended trading on Tuesday after it was announced the company will join the S&P Midcap 400.
12-24 07:15
UiPath, Versant Media to join S&P MidCap 400 and SmallCap 600
S&P Dow Jones Indices said on Tuesday that UiPath (PATH) will replace Synovus Financial (SNV) in the S&P MidCap 400, effective January 2, 2026, following Synovus’s pending acquisition by Pinnacle Fina...
12-24 07:06
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
12-22 15:05
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
12-17 10:46
JP Morgan Maintains Overweight on Pinnacle Finl Partners, Raises Price Target to $125
JP Morgan analyst Anthony Elian maintains Pinnacle Finl Partners (NASDAQ:PNFP) with a Overweight and raises the price target from $110 to $125.
12-17 00:00
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
B of A Securities Initiates Coverage On Pinnacle Finl Partners with Buy Rating, Announces Price Target of $113
B of A Securities analyst Ebrahim Poonawala initiates coverage on Pinnacle Finl Partners (NASDAQ:PNFP) with a Buy rating and announces Price Target of $113.
12-08 21:29
Synovus Announces New Board for Upcoming Merger
The latest update is out from Synovus ( ($SNV) ). On July 24, 2025, Synovus Fin...
12-02 06:05
